NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 72 filers reported holding NEXTCURE INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,957 | -28.3% | 10,044 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $18,079 | +21.6% | 10,044 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $14,865 | +5.0% | 10,044 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $14,162 | -49.4% | 10,044 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $28,000 | -40.4% | 10,044 | 0.0% | 0.01% | -40.0% |
| Q2 2022 | $47,000 | -4.1% | 10,044 | 0.0% | 0.02% | +50.0% |
| Q1 2022 | $49,000 | -18.3% | 10,044 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $60,000 | -11.8% | 10,044 | 0.0% | 0.01% | +33.3% |
| Q3 2021 | $68,000 | -16.0% | 10,044 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $81,000 | -19.8% | 10,044 | 0.0% | 0.01% | -42.9% |
| Q1 2021 | $101,000 | -7.3% | 10,044 | 0.0% | 0.01% | -67.4% |
| Q4 2020 | $109,000 | +23.9% | 10,044 | 0.0% | 0.04% | +30.3% |
| Q3 2020 | $88,000 | -59.1% | 10,044 | 0.0% | 0.03% | -64.5% |
| Q2 2020 | $215,000 | -42.2% | 10,044 | 0.0% | 0.09% | -48.3% |
| Q1 2020 | $372,000 | – | 10,044 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
| Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
| Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
| DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
| Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
| Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
| Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |